-
NHS injects $160m into ‘elective accelerators’ to combat waiting lists
pharmatimes
May 14, 2021
NHS England has injected $160m into ‘elective accelerator’ sites with the aim of reducing waiting lists by introducing new and ‘innovative’ ways of working.
-
New NHS legislation provides ‘once-in-a-decade opportunity’ to centre research
pharmatimes
May 13, 2021
New legislation for the NHS has been announced in the latest Queen’s speech, along with plans to build on the success of the vaccination programme in a bid to boost life sciences in the UK.
-
NHS rolls out 3D heart scans to fast-track diagnosis of heart disease
pharmatimes
May 07, 2021
The NHS has announced the introduction of new 3D heart scans to fast-track diagnosis for approximately 100,000 patients with suspected heart disease.
-
Daiichi Sankyo’s cholesterol-lowering drugs recommended for NHS use
pharmatimes
April 30, 2021
The UK’s National Institute for Health and Care Excellence (NICE) has recommended Daiichi Sankyo’s cholesterol drugs Nilemdo and Nustendi for use on the NHS, benefitting around 70,000 adults in England with high cholesterol.
-
NHS leaders warn of a ‘chronic undersupply’ of staff
pharmatimes
April 23, 2021
NHS leaders have warned that the health service in the UK is facing a ‘chronic undersupply’ of staff in a joint letter sent to Prime Minister Boris Johnson.
-
New report suggests the gender pay gap for doctors increased during pandemic
pharmatimes
April 23, 2021
A new report suggests that the gender pay gap for doctors has increased during the pandemic, with female doctors found to be disproportionately affected by falling earnings.
-
Experts call for advanced radiotherapy funding to address COVID-19 cancer care backlog
pharmatimes
April 13, 2021
The Institute for Cancer Research, London (ICR) is urging the government to invest in advanced radiotherapy in a bid to address the backlog in NHS cancer care that has accumulated during the COVID-19 pandemic.
-
NHS extends ‘COVID-friendly’ at-home cancer care
pharmatimes
March 31, 2021
The NHS has announced that thousands of people will benefit from the extension of ‘COVID-friendly’ cancer treatments which can be taken at home.
-
Novartis UK signs digital partnership with Cievert for chronic disease management
pharmatimes
March 30, 2021
Novartis UK and digital health company Cievert have announced a digital innovation partnership to help streamline the management of rheumatological and dermatological diseases.
-
NHS England makes Keytruda available for advanced colorectal cancer during pandemic
pharmatimes
March 29, 2021
NHS England has reached an interim treatment agreement with MSD for Keytruda for the treatment of certain advanced colorectal cancer patients during the COVID-19 pandemic.